Latest News

New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates

April 16th 2024

Five experts delved into the latest updates to treatment guidelines and the updated label use for dupilumab for hand-foot AD.

Treatment With Tralokinumab Improved Epidermal Pathology, Reduced Systemic Markers In Type 2 Inflammation
Treatment With Tralokinumab Improved Epidermal Pathology, Reduced Systemic Markers In Type 2 Inflammation

April 12th 2024

Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues
Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues

April 11th 2024

Countdown to RAVE!
Countdown to RAVE!

April 5th 2024

Managing Mental Health Comorbidities in Adult Patients With Atopic Dermatitis
Managing Mental Health Comorbidities in Adult Patients With Atopic Dermatitis

April 5th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.